Device Trial Radar · NCT02793492
Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery
Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
75
Actual
Start
Aug 30, 2022
Primary completion
Feb 24, 2025
Study completion Jul 1, 2026
Sponsor
- Lead sponsor
- Terumo Medical CorporationPublic (4543.T)
- Sponsor type
- Industry
- First posted
- Jun 8, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.
Conditions
- Iliac Artery Stenosis
Interventions
Misago® RX Self-expanding Peripheral StentDevice
the Misago® RX Self-expanding Stent is a bare metal, nitinol stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from the composite Major Adverse Event rate, defined as periprocedural related death, amputation of the target limb, and clinically driven TLR assessed at 9 months post-procedure.Time frame: 9 months post-procedure
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
ClinRe Inc. Advanced Heart and Vein Center
Thornton, Colorado
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.